Presentation is loading. Please wait.

Presentation is loading. Please wait.

Keratinocyte growth factor (KGF) versus no KGF for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic.

Published byGiles Warner Modified over 5 years ago

Similar presentations

Presentation on theme: "Keratinocyte growth factor (KGF) versus no KGF for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic."— Presentation transcript:

1 Keratinocyte growth factor (KGF) versus no KGF for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. Keratinocyte growth factor (KGF) versus no KGF for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. Forest plot of incidence of severe (grade 3 or 4) mucositis in adults and children randomised to KGF versus no KGF in patients with cancer and those receiving haematopoietic stem cell transplantation. Squares to the left of the vertical line indicate that the intervention reduces mucositis. Horizontal lines through the squares represent CIs. The size of the squares reflects each study's relative weight, and the diamond represents the aggregate risk ratio and 95% CI. Lillian Sung et al. BMJ Support Palliat Care doi: /bmjspcare ©2015 by British Medical Journal Publishing Group

Download ppt "Keratinocyte growth factor (KGF) versus no KGF for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic."

Similar presentations

Physical Exercise for Patients Undergoing Hematopoietic Stem Cell Transplantation: Systematic Review and Meta- Analyses of Randomized Controlled Trials.

Physical Exercise for Patients Undergoing Hematopoietic Stem Cell Transplantation: Systematic Review and Meta- Analyses of Randomized Controlled Trials.
Forest plot of the diagnostic yield of combined transbronchial needle aspiration (TBNA) and transbronchial lung biopsy (TBLB) in patients with sarcoidosis.

Forest plot of the diagnostic yield of combined transbronchial needle aspiration (TBNA) and transbronchial lung biopsy (TBLB) in patients with sarcoidosis.
Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of.

Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of.
Videolaryngoscope versus Macintosh laryngoscope for tracheal intubation in adults with obesity: A systematic review and meta-analysis  Hiroshi Hoshijima,

Videolaryngoscope versus Macintosh laryngoscope for tracheal intubation in adults with obesity: A systematic review and meta-analysis  Hiroshi Hoshijima,
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,

Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
(A) Participation rates of primary care paediatricians per region in Bavaria (blue) and the mean number of children screened per primary care paediatrician.

(A) Participation rates of primary care paediatricians per region in Bavaria (blue) and the mean number of children screened per primary care paediatrician.
Ashish Shukla et al. JACEP 2015;1:41-51

Ashish Shukla et al. JACEP 2015;1:41-51
Incidence trends for each human papillomavirus-related cancer-type among women in Norway 1953–2015. Incidence trends for each human papillomavirus-related.

Incidence trends for each human papillomavirus-related cancer-type among women in Norway 1953–2015. Incidence trends for each human papillomavirus-related.
Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.

Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.
Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)

Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)
DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.

DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.
Scatter graph showing the total number of specialist palliative care beds commissioned compared with the estimated number of people with palliative care.

Scatter graph showing the total number of specialist palliative care beds commissioned compared with the estimated number of people with palliative care.
Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.

Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.
Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.
Yousef Rezaei, MD  American Journal of Kidney Diseases 

Yousef Rezaei, MD  American Journal of Kidney Diseases 
A Pilot Randomized Controlled Trial of an Oral Care Intervention to Reduce Mucositis Severity in Stem Cell Transplant Patients  Prisco Salvador, RN, MScN,

A Pilot Randomized Controlled Trial of an Oral Care Intervention to Reduce Mucositis Severity in Stem Cell Transplant Patients  Prisco Salvador, RN, MScN,
Toshiaki Toyota et al. JCIN 2017;10:27-37

Toshiaki Toyota et al. JCIN 2017;10:27-37
Mean (±95%CI) relative delta power at baseline, at the end of treatment and 6 months after the end of treatment in patients with cirrhosis (n=5, black.

Mean (±95%CI) relative delta power at baseline, at the end of treatment and 6 months after the end of treatment in patients with cirrhosis (n=5, black.
Volume 76, Issue 11, Pages (December 2009)

Volume 76, Issue 11, Pages (December 2009)
Scatterplot showing the association between baseline weight and weight change at 1 year, relative to baseline for each treatment group. Scatterplot showing.

Scatterplot showing the association between baseline weight and weight change at 1 year, relative to baseline for each treatment group. Scatterplot showing.

Similar presentations

Ads by Google